Clinical Trial Update: A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Calderasib (MK-1084) in combination with targeted therapy and chemotherapy for colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma
• Colorectal Cancer
• Rectal Adenocarcinoma

Drugs mentioned

• Calderasib (MK-1084)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Colon Adenocarcinoma, Rectal Adenocarcinoma | Phase 3 | Status: RECRUITING